Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
idiopathic pulmonary fibrosis
Biotech
Fibrosis-focused Endeavor bags $132.5M series C
Endeavor BioMedicines is $132.5 million richer, courtesy of another nine-digit financing round that plows additional cash runway through 2026.
Max Bayer
Apr 24, 2024 7:30am
Surrozen's Wnt mimetic antibody works in mice with lung fibrosis
Apr 4, 2024 4:30am
J&J-allied bio files IPO to take fight to BMS, Roche and more
Mar 18, 2024 7:15am
FDA greenlights AI for diagnosing idiopathic pulmonary fibrosis
Jan 16, 2024 12:43pm
BMS charts 2nd pulmonary fibrosis win with LPA1 antagonist
Sep 11, 2023 10:05am
Galecto cans lung fibrosis med after ph. 2 fail, pivots to liver
Aug 15, 2023 7:30am